Navigation Links
Arno Therapeutics to Present Positive, New Data Supporting the Potential of Onapristone in Endometrial and Breast Cancers at ASCO 2013 Annual Meeting
Date:5/15/2013

FLEMINGTON, N.J., May 15, 2013 /PRNewswire/ -- Arno Therapeutics, Inc. (OTCQB: ARNI), a clinical stage biopharmaceutical company focused on the development of oncology therapeutics, today announced new, positive data from three studies supporting its investigational compound onapristone to be presented at the American Society of Clinical Oncology (ASCO) 2013 Annual Meeting, which is being held May 31-June 4, 2013 in Chicago, Illinois.

Three separate preclinical studies support further investigation of onapristone - an orally-administered, investigational type 1 progestin receptor antagonist - and the development of a diagnostic test for the compound to identify patients with activated progesterone receptor (APR) as a potential biomarker of anti-progestin activity in endometrial and breast cancers.  Recently, Arno Therapeutics announced its collaboration with Clarient Diagnostic Services Inc., a GE healthcare company, and leading provider of cancer diagnostic testing, to develop a diagnostic test to identify cancerous tumors with APR.

Onapristone is believed to work by binding to a protein called the progesterone receptor, thereby inhibiting dimerization, phosphorylation and DNA transcription activity. Progesterone receptors (PRs) are found in particular cells including those of the female reproductive tissue and some cancers.[i] The hormone progesterone binds to the receptors and may cause the cells to grow.i  Preclinical studies have shown that PRs can play a role as drivers of malignant cell growth in certain cancers."We are pleased with the findings as they support the development of a diagnostic test for onapristone to help identify patients with activated progesterone receptors in endometrial and breast cancers who are most likely to benefit from treatment in these difficult-to-treat diseases," said Glenn Mattes , chief executive officer
'/>"/>

SOURCE Arno Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cell Therapeutics, Inc. (CTI) to Report First Quarter Financial Results on April 20
2. Faruqi & Faruqi, LLP Encourages Investors Who Suffered Substantial Losses Investing in Chelsea Therapeutics International, Ltd. to Contact the Firm
3. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
4. Novelos Therapeutics Announces Successful Completion of First Cohort In Lung Cancer Trial With I-124-CLR1404 (LIGHT) Cancer-Targeted PET Imaging Agent at UW Carbone Cancer Center
5. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
6. Oxford BioTherapeutics Appoints Senior Industry Leader to Head its New Clinical Development Operations in Basel, Switzerland
7. Nektar Therapeutics Reports Financial Results for the First Quarter of 2012
8. Cara Therapeutics Licenses Novel Kappa Opioid Agonist, CR845, to Chong Kun Dang Pharmaceutical Corporation For South Korean Market
9. Frost & Sullivan: High Uptake of New Drug Therapies and Aging Population Expansion Keep the U.S. Retinal Therapeutics Market Buoyant
10. Zenobia Therapeutics, Inc. And BioBlocks, Inc. Announce Sale Of A Joint Fragment Library Ideal For Screening By All Popular Methods
11. New Forecast Shows Global Protein Therapeutics Market to Reach $143.4 Billion by 2015
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)...  Eli Lilly and Company (NYSE: LLY ) ... of its intent to end its contract with the ... Asymptomatic Alzheimer,s disease (A4) study. The A4 study is ... stage of Alzheimer,s disease in older individuals who have ... scan, but do not show symptoms of memory impairment. ...
(Date:8/4/2015)... 4, 2015  Sangamo BioSciences, Inc. (NASDAQ: SGMO ... Ch.B., Sangamo,s executive vice president, research and development, will ... Therapeutic ® development programs and an overview of ... August 11, 2015, at the 2015 Wedbush Pacgrow Healthcare ... New York, NY . The presentation ...
(Date:8/4/2015)... Calif., Aug. 4, 2015  Xencor, Inc. (NASDAQ: ... engineered monoclonal antibodies for the treatment of autoimmune ... reported financial results for the second quarter ended June ... business highlights. "Currently eight XmAb® antibody ... and two internal. The accelerating momentum of this ...
Breaking Medicine Technology:Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 2Lilly to End Contract with the University of California, San Diego for A4 Alzheimer's Study 3Sangamo BioSciences Announces Presentation At The 2015 Wedbush Pacgrow Healthcare Conference 2Xencor Reports Second Quarter 2015 Financial and Operating Results 2Xencor Reports Second Quarter 2015 Financial and Operating Results 3Xencor Reports Second Quarter 2015 Financial and Operating Results 4Xencor Reports Second Quarter 2015 Financial and Operating Results 5Xencor Reports Second Quarter 2015 Financial and Operating Results 6Xencor Reports Second Quarter 2015 Financial and Operating Results 7Xencor Reports Second Quarter 2015 Financial and Operating Results 8Xencor Reports Second Quarter 2015 Financial and Operating Results 9
... ago, Keli Babcock faced a crisis. A medical condition was ... a ventilator. She couldn,t walk or even maneuver a manual ... But Keli wasn,t about to give in; she aspired to ... with a power wheelchair, one that is powered by batteries ...
... Innovative wireless technology is reshaping the healthcare landscape in ... of Wireless" webcast ( www.ctia.org ) focuses on new ... more value and better health. This is particularly true ... of the U.S. population suffers from at least one ...
Cached Medicine Technology:Mobility Matters: Power Wheelchairs Change the Lives of Medicare Beneficiaries 2Mobility Matters: Power Wheelchairs Change the Lives of Medicare Beneficiaries 3Mobility Matters: Power Wheelchairs Change the Lives of Medicare Beneficiaries 4CTIA-The Wireless Association® November Edition of 'Wonder of Wireless' and Blog to Focus on mHealth 2CTIA-The Wireless Association® November Edition of 'Wonder of Wireless' and Blog to Focus on mHealth 3
(Date:8/4/2015)... ... 05, 2015 , ... Renowned review site BestMillionaireDatingSites.com recently refreshed its list of ... been ranked as the best dating service in the segment. , A representative from ... is essential that people find the right dating platform so that they can make ...
(Date:8/4/2015)... ... August 04, 2015 , ... NOVA Pride , Northern ... or how they love or identify, to join them in paving “The Road Ahead” ... Special Events Center on Saturday, October 3, 2015, from 12-9pm. In order to ensure ...
(Date:8/4/2015)... ... , ... Statement by Paul Gionfriddo, President and CEO, Mental Health America , ... Act of 2015 by Senators Bill Cassidy and Christopher Murphy. It is ... , “This legislation and H.R. 2646 [The Helping Families in Mental Health ...
(Date:8/4/2015)... ... August 04, 2015 , ... Sponsored by Gila River ... which is a 501(c) nonprofit organization. , According to the New Foundation AZ ... will get a package that includes a complimentary foursome for the tournament, as well ...
(Date:8/4/2015)... ... August 04, 2015 , ... Exsurco Medical, Inc. ... Tissue Banks (AATB) as an Affiliate Member. Exsurco Medical finds this an ... save and improve lives by promoting the safety, quality and availability of donated ...
Breaking Medicine News(10 mins):Health News:BestMillionaireDatingSites.com Publishes Reviews of the Best Dating Sites for Wealthy Singles 2Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 2Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 3Health News:NOVA Pride Announces Theme for the 2015 Northern Virginia Pride Festival 4Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 2Health News:MHA Applauds Introduction of Mental Health Reform Act of 2015 3Health News:The New Foundation AZ to Host Charity Golf Tournament 2Health News:The New Foundation AZ to Host Charity Golf Tournament 3Health News:Exsurco Medical Joins AATB as Affiliate Member 2
... a new definition to identify children and adolescents ... diabetes and cardiovascular disease in later life. The ... ,The metabolic syndrome is a cluster of the most ... disease. Its early identification is very important to facilitate ...
... Rachel Hunter became quite worried about her weight after a ... ,The former wife of rocker Rod Stewart is the ... that she was really concerned about her weight when the ... what's wrong with me? Do I look fat," Contactmusic quoted ...
... annual HealthGrades Womens Health Outcomes in U.S. Hospitals ... nation's best- performing hospitals have a 39 percent ... women at the nation's poorest-performing hospitals. ... largest quality gaps between the best-performing and poorest-performing ...
... reportedly planning to undergo a foot surgery . ... because of her painful bunions and has decided to get ... enough of having bad feet and has made some early-stage ... Mail quoted the source, as saying. ,"They are ...
... Mumbai, June 25 (IANS) Indian pharmaceutical major Ranbaxy Laboratories ... pravastatin sodium tablets, meant for heart diseases . ... 180-day exclusivity for the pravastatin 80mg and benefit from ... Bombay Stock Exchange (BSE). ,The annual sales ...
... is more effective than one-on-one phone counseling. As Americans ... provide feedback and motivation can play a crucial role ... ,Researchers found feedback delivered via mail was equally ... and potentially more effective long-term than feedback delivered via ...
Cached Medicine News:Health News:New Definition Helps Identify Children at Risk of Metabolic Syndrome 2Health News:Best-performing Hospitals Has Reduced Cardiovascular Mortality 2Health News:Physical Activity can Be Increased by a Motivating Mail 2Health News:Physical Activity can Be Increased by a Motivating Mail 3
... The Tomey Pachymeter SP-3000 covers all ... the general ophthalmic health care., ,Compact design, ... the SP-3000 to be an "easy-to-use unit.,The ... 1500 mm gives you the possibility to ...
The PillCam™ ESO video capsule is specifically designed to view the inner lining of the Esophagus. The capsule is equipped with miniature cameras on both ends and is about the size of a multi-v...
... combines three advanced technologies - plus ... refractive diagnostic workstation. Now, with a ... corneal topography, optical path difference (OPD) ... allows you to evaluate your patient ...
World's first commercially available vacuum assisted biopsy device for MRI....
Medicine Products: